Investor Relations Overview
Mylan Inc. is a leading pharmaceutical company with three subsidiaries,
Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc.
that develop, manufacture and market an extensive
line of generic and proprietary products.
Latest News
| 7/25/2005 - Mylan Announces Tentative Approval for Ondansetron Hydrochloride Tablets |
| 10/25/2005 - Icahn Drops Mylan Litigation for the Second Time |
| 12/25/2005 - 05 Mylan Announces Final Results of its Modified
'Dutch Auction' Self Tender Offer and Closing of Related Financing |
| 10/25/2005 - Mylan Updates Status on Topiramate Summary Judgment Motion |